febit Appoints Heinz Blunier as COO

LEXINGTON, Mass. (USA), and HEIDELBERG, Germany, (PresseBox) - febit holding GmbH, a developer of the flexible and automated biochip-based DNA-analysis platform Geniom®, today announced the appointment of Heinz Blunier, to the newly created position of Chief Operation Officer.

Blunier previously served as Head of Engineering Department at Inventa, CEO of Tegimenta AG, a subsidiary of Hoffmann-La-Roche, and Vice President Plant Manager at Boehringer Mannheim. As an independent management consultant he led numerous production and operations projects in Switzerland, Germany and UK mainly in the field of scientific instrumentation.

As COO Heinz Blunier is responsible for instrument production, the technical service, production of Geniom biochips, the Geniom biochip farm as well as the complete supply chain. Blunier has more than 30 years of experience in medical and analytical instrumentation in different positions. He will be based in febit's headquarter in Heidelberg.

Hummingbird Diagnostics GmbH

febit develops, produces and markets flexible automated solutions for enabling biochip applications in Life Sciences. The product portfolio spans various instruments, assay protocols and bioanalytical services and is complemented by bioinformatics software and consulting.

For it's main applications HybSelect, febit's innovative DNA capture method for Next-Generation-Sequencing as well as for protein-coding and non-coding transcriptomic profiling, the highly elaborated microfluidics of the patented Geniom Biochip offer the highest degree of automation, flexibility and efficiency throughout the field.

For more information please visit: www.febit.com

Press releases you might also be interested in

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.

I want to subscribe to the gratis press mail and have read and accepted the conditions.